All articles by GlobalData Healthcare

Biotech bounces back as venture funding grows $3.8m from 2023 to 2024YTD

Following a challenging two-year downturn, private biopharmaceutical venture financing saw a 20% ($3.8 million) increase in total deal value from…
Reprieve for WuXi as Biosecure vote likely pushed to 2025

The Biosecure Act was left out of a key US defence bill that passed in the House last week, in…
ASH 2024 discussions shine spotlight on advances in haemophilia treatments

At the American Society of Hematology (ASH) Annual Meeting 2024, physicians looked back at the progress made in the prophylactic…
Lilly’s £279m bet aims to boost UK life sciences sector

Leading obesity drugmaker Lilly has announced a £279m ($365.5m) investment in the UK in a major collaboration between the company…
ASH 2024: J&J’s Tecvayli shows promise in transplant-eligible NDMM patient

The prevailing treatment paradigm for newly diagnosed multiple myeloma (NDMM) patients who have received autologous stem cell transplantation (SCT) primarily…

ASH 2024: Regeneron’s Ordspono faces challenges, but positive results signal hope

Data from the Phase II ELM-2 trial was presented at the American Society of Hematology (ASH) 2024 Annual Meeting, held…
RSV prophylactic market to reach $6.2bn in 8MM by 2030

The respiratory syncytial virus (RSV) prophylaxis market across the eight major markets (8MM) - comprising the US, the five major…
Cell and gene therapy companies must demonstrate strong value proposition for investment

Investment for companies developing cell and gene therapies (CGTs) was discussed during the GenScript Biotech Global Forum London 2024 conference…
From Cobenfy to Emraclidine: the muscarinic path to safer antipsychotics

On 26 September 2024, Cobenfy (KarXT) gained US Food and Drug Administration (FDA) approval as the first novel class of…
Airways unbound: The biologic revolution in asthma treatment

In recent years, the evolution of biologic therapies for severe asthma has paralleled advancements in other chronic conditions such as…